Search results
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
Motley Fool via Yahoo Finance· 6 days agoDirect competition between the companies, most likely in the domain of antibody-drug conjugates...
A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral...
Morningstar· 6 days agoSHELTON, CT / ACCESSWIRE / May 29, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, elaborates on its ...
Feds plan for smoother access to RSV infant shot
Politico· 6 days agoThe company can use the voucher to expedite the review of a future drug or sell it to another drugmaker. The FDA is co-sponsoring a public workshop on using patient-generated health data in ...
Healthful Hints: Flirting with new COVID variants
La Crosse Tribune· 3 days agoNew COVID mutations and variants have recently been identified participating in the viral pool of infections. People have not been thinking of COVID and...
Researchers are working on a new mRNA vaccine—this time for bird flu
Fast Company Magazine· 7 days agoThe H5N1 subtype of avian flu has spread among both poultry and cattle and has already infected...
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock | The Motley Fool
The Motley Fool· 6 days agoAs two of the world's largest and most prolific drugmakers, Pfizer (PFE -1.70%) and AstraZeneca (AZN...
FDA approves Moderna’s mRNA RSV vaccine for older adults | CNN
CNN.com· 4 days agoThe US Food and Drug Administration has approved another vaccine to help protect older people from...